100
Participants
Start Date
December 1, 2020
Primary Completion Date
December 16, 2021
Study Completion Date
December 16, 2022
CBD Oral Disintegrating Tablet (ODT)
Cohort 1: CBD ODTs to be administered with routine post-operative pain management regimen
Placebo ODT
"Cohort 2 will not receive CBD; but a visually indistinguishable placebo ODT instead.~The resident physician, physician assistant, anesthesiologist, surgeon and study team members will remain blinded. Additionally, all patients will receive a traditional upper extremity interscalene block as per routine."
NYU Langone Health, New York
Collaborators (1)
Orcosa Inc.
INDUSTRY
NYU Langone Health
OTHER